Cargando…
Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19
Background: Neurological symptoms (NS) in COVID-19 are related to both acute stage and long-COVID. We explored levels of brain injury biomarkers (NfL and GFAP) and myeloid activation marker (sCD163) and their implications on the CNS. Materials and Methods: In hospitalized COVID-19 patients plasma sa...
Autores principales: | Zingaropoli, Maria Antonella, Pasculli, Patrizia, Barbato, Christian, Petrella, Carla, Fiore, Marco, Dominelli, Federica, Latronico, Tiziana, Ciccone, Federica, Antonacci, Michele, Liuzzi, Grazia Maria, Talarico, Giuseppina, Bruno, Giuseppe, Galardo, Gioacchino, Pugliese, Francesco, Lichtner, Miriam, Mastroianni, Claudio Maria, Minni, Antonio, Ciardi, Maria Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526816/ https://www.ncbi.nlm.nih.gov/pubmed/37759493 http://dx.doi.org/10.3390/cells12182270 |
Ejemplares similares
-
Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023) -
COVID-19 Affects Serum Brain-Derived Neurotrophic Factor and Neurofilament Light Chain in Aged Men: Implications for Morbidity and Mortality
por: Petrella, Carla, et al.
Publicado: (2023) -
Blood Biomarkers from the Emergency Department Disclose Severe Omicron COVID-19-Associated Outcomes
por: Pennacchia, Fiorenza, et al.
Publicado: (2023) -
Evaluation of BAFF, APRIL and CD40L in Ocrelizumab-Treated pwMS and Infectious Risk
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2023) -
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients
por: Zingaropoli, Maria Antonella, et al.
Publicado: (2022)